Comprehensive Blood Panel

One blood draw, many lab results — blood count, blood sugar, cholesterol, liver and kidney, plus thyroid when there is a reason — each read against the laboratory's own reference range.

Last updated October 2026 · New Dawn Health editorial team

Draw time
A few minutes for the blood draw
Radiation
None — a blood test, not imaging
Preparation
Depends on the ordered tests; confirm before the visit
Report
Analytes, ranges, language, and timing vary by clinic

What is a comprehensive blood panel?

A comprehensive blood panel is a single blood draw that runs many laboratory tests at once. A screening panel checks several systems together — blood, metabolism, blood fats, organ function and hormones — in someone who feels well.

Some common conditions, such as prediabetes, an underactive thyroid or early kidney strain, can be silent for years. They may first show up as a number drifting outside its reference range.

A phlebotomist presses a dressing to a seated patient's inner elbow, a rack of filled color-capped tubes beside them.
Many results ride out of one short sitting. Each cap color routes its tube to a different laboratory bench.

What it measures

Exact tests vary by package; the listing further down shows each one. A panel usually draws from these groups:

Common laboratory groups in a screening blood panel, and the question each one answers.
Group What it measures The question it answers
Complete blood count (CBC) Red cells, white cells and platelets Anemia, infection, some blood disorders
Metabolic markers Fasting glucose and HbA1c Diabetes and prediabetes
Lipid panel Cholesterol (including LDL) and triglycerides Cardiovascular risk
Liver and kidney function Liver enzymes; creatinine and filtration markers How those organs are coping
Thyroid hormones (when there is a reason) TSH and related levels An over- or underactive thyroid
Tumor markers (some packages) Such as AFP, CEA, CA 19-9, CA-125 and PSA Not a cancer screen — see below

Reading your results, marker by marker

A blood panel is not one test. It is many tests printed on the same page, and most of the page is unexplained. Below are the markers that drive decisions, and what a number outside its range does and does not mean.

Metabolic — HbA1c

Fasting glucose shows what your blood sugar was doing at the moment of the draw. HbA1c is not a snapshot. Glucose in your blood sticks to the hemoglobin inside red blood cells, and it keeps sticking for as long as those cells circulate. So the share of hemoglobin carrying sugar reports your average blood sugar over about the past three months. You cannot fast your way to a good HbA1c the night before.

The American Diabetes Association uses these bands:

Below 5.7%
Normal. Average blood sugar sits in the expected range.
5.7–6.4%
Prediabetes range. Blood sugar is running higher than normal but has not reached the diabetes threshold. It is usually silent, and it is the band where lifestyle change does the most work.
6.5% or above
Diabetes range. Meets the diagnostic threshold, but a diagnosis is normally confirmed first — by repeating the test, or by a second test such as fasting glucose. This one goes to a physician.

A ladder like this is the general pattern, not a rule your case must obey. Reporting conventions differ between hospitals, and two experienced clinicians can read the same finding and reasonably advise differently. Where your report or your doctor differs from this table, go with them — they are looking at your actual result.

  • HbA1c can mislead in some people. NIDDK notes that iron-deficiency anemia, recent blood loss, kidney or liver disease, and hemoglobin variants such as thalassemia trait can make it read falsely high or low. A clinician may then rely on glucose tests instead.
  • Prediabetes is a window, not a verdict. In the US Diabetes Prevention Program trial, people with raised blood sugar who made structured lifestyle changes cut their rate of developing diabetes by 58% over about three years.

Liver — ALT and AST

ALT and AST are enzymes that live inside liver cells. They appear in the blood in quantity when liver cells are stressed or inflamed and leak their contents. So a raised ALT measures leakage, a sign of irritation somewhere in the liver, not damage directly. The cut-off for "high" varies by laboratory and by sex.

In people without symptoms, the American Academy of Family Physicians lists fatty liver disease as the most common cause of a mildly raised ALT. Other causes to rule out:

  • Alcohol
  • Medicines and supplements that stress the liver
  • Viral hepatitis, including hepatitis B and C

Blood work can raise the suspicion of fatty liver disease, but it cannot see fat. If a clinician wants to look, an abdominal ultrasound images the liver directly. A markedly raised ALT, or one climbing across repeat draws, belongs with a physician.

Cardiovascular — the lipid panel

A lipid panel reports total cholesterol, HDL, triglycerides and LDL, and LDL is the number that drives decisions. A 2017 European Atherosclerosis Society consensus treats LDL as a cause of heart disease, not just a marker. LDL particles physically enter the artery wall and are the raw material plaque is built from. That is why lowering LDL lowers heart attacks rather than merely improving a number.

Tumor markers — CEA, CA-125, AFP, PSA

Tumor markers are substances, mostly proteins, that some tumors release into the blood — and that healthy or irritated tissue releases too. CEA is linked with colorectal and some other cancers, CA-125 with ovarian cancer, AFP with liver cancer, and PSA is made by the prostate.

The false alarms are common, not theoretical. Benign reasons for a raised marker include:

  • CEA: smoking, which raises CEA levels, and inflammation of the gut, liver or lungs
  • CA-125: a menstrual period, pregnancy, endometriosis, fibroids, pelvic inflammatory disease and liver disease
  • Each false alarm costs something: a period of fear and follow-up tests, some with their own risks

This is why major guideline bodies do not recommend tumor markers for cancer screening in the general population, and they say it separately:

What named guideline bodies say about tumor markers as screening tests.
Body Position
US National Cancer Institute Circulating tumor markers have generally not worked well for screening
US Preventive Services Task Force Recommends against ovarian cancer screening in women without symptoms, CA-125 included
ASCO (2006) Does not recommend CEA as a screening test for colorectal cancer

PSA is the exception worth stating separately. Rather than a flat recommendation against, the USPSTF frames PSA screening for men aged 55–69 as an individual decision made after discussing benefits and harms with a clinician. It recommends against it for men aged 70 and over.

That reflects the Task Force's 2018 statement, which is currently under review — worth checking for an update if you are weighing this.

  • Where markers do earn their place: monitoring a known cancer during and after treatment, under a specialist.
  • One high-risk exception: AASLD guidance uses AFP with ultrasound to watch people with cirrhosis or some cases of chronic hepatitis B — a specialist's surveillance plan, not a general screen.
  • If your panel includes them anyway, a single value means little on its own. Ask a physician to interpret any raised result before acting on it.

Thyroid — TSH

TSH is the pituitary gland's instruction to the thyroid, and it moves the opposite way you might expect. A high TSH usually means the pituitary is shouting because the thyroid is under-producing; a low TSH often means the reverse. That sensitivity is why it is the standard first-line thyroid test.

What it can't tell you

What blood work can show
  • Blood sugar, blood fats and blood count against a laboratory range
  • Signs that the liver, kidneys or thyroid are under strain
  • Change over time, when the same tests are repeated
What it cannot do
  • Screen for cancer. Tumor markers miss cancers and flag people without one. Proven cancer screening is test-specific, such as stool testing or colonoscopy for colorectal cancer.
  • Show what an organ looks like. A raised liver enzyme hints at a problem; an abdominal ultrasound looks at the liver when a clinician asks.
  • Show plaque in the arteries. Cholesterol is the raw material; a calcium score measures calcified plaque, selectively.
  • Diagnose from one value. A single out-of-range result is a question. Many are repeated, or followed by your own doctor's targeted tests, before anything is decided.

Who it helps — and who it does not

Which tests make sense depends on age, history, symptoms and risk, not on the size of the panel. It tends to help:

  • Adults who have not had basic checks such as blood sugar and cholesterol for some years
  • People with a family history of diabetes or early heart disease, or a known thyroid condition

It adds less in these situations:

  • You want a cancer check. A blood panel is not one; ask about the screening tests recommended for your age.
  • You are already under care for diabetes, liver, kidney or thyroid disease. Your own doctor's tests come first.
  • You have symptoms. They need a doctor's assessment, not a screening panel.

Before your blood draw

  1. 1
    Check whether you need to fast
    Fasting is test-specific. A fasting glucose needs at least 8 hours without food. HbA1c does not need fasting. US cholesterol guidance (ACC/AHA 2026) accepts a non-fasting lipid panel for most people, with a repeat fasting sample when non-fasting triglycerides are above 400 mg/dL. Plain water is usually fine — your coordinator confirms the rules for your tests when you book.
  2. 2
    Medicines and fasting
    If you take insulin or other diabetes medicines, ask before fasting how to adjust them. Mention biotin supplements too, because they can distort some lab tests. Any other test-specific rules, such as not smoking before a CEA test, your coordinator confirms when you book.
  3. 3
    The draw itself
    A nurse fills a few small tubes from a vein in your arm. It takes only a few minutes.
  4. 4
    Eat and carry on
    There is no recovery time. Have breakfast and continue with your day.

Cost and coverage

The live price further down this page is the booking price at New Dawn Health; anything billed separately — such as biopsy or pathology where it applies — is confirmed when you book. What happens after that depends on where your coverage comes from:

  • In Taiwan, screening is paid for by the visitor. Short-term visitors are not covered by Taiwan's National Health Insurance, so screening is self-funded.
  • Reimbursement at home is a question for your insurer. Ask them before you book, and ask which documents they need.
  • The exact test list varies by package. Check the listing below before you book.

Results & follow-up

  • A report listing each value next to its reference range. Which tests, the report language and turnaround are confirmed when you book.
  • Out-of-range results are a question, not an answer. The usual next step is a repeat test, a targeted test, or taking the result to your own doctor.
  • Keep your results. Trends across years say more than any single draw.

Sources & further reading

  1. [1] Thyroid Dysfunction: Screening (2015, "I" statement for nonpregnant adults without symptoms) — US Preventive Services Task Force
  2. [2] Tumor Markers — fact sheet — National Cancer Institute
  3. [3] Comprehensive Metabolic Panel (CMP) — MedlinePlus (NIH)
  4. [4] Ovarian cancer: screening — US Preventive Services Task Force
  5. [5] Prostate cancer: screening — US Preventive Services Task Force
  6. [6] Mildly elevated liver transaminase levels — American Academy of Family Physicians
  7. [7] Thyroid function tests — American Thyroid Association
  8. [8] Understanding A1C — diagnostic ranges — American Diabetes Association
  9. [9] ASCO 2006 recommendations for tumor markers in gastrointestinal cancer (Locker 2006) — PubMed / Journal of Clinical Oncology
  10. [10] The A1C test and diabetes — 3-month average, no fasting, 8-hour fast for glucose tests, false results — NIH / NIDDK
  11. [11] Diabetes Prevention Program: lifestyle intervention reduced diabetes incidence by 58% (Knowler 2002) — New England Journal of Medicine / PubMed
  12. [12] 2026 ACC/AHA guideline on the management of dyslipidemia — non-fasting lipid testing; repeat fasting when triglycerides are above 400 mg/dL — Circulation (American Heart Association) — DOI
  13. [13] Low-density lipoproteins cause atherosclerotic cardiovascular disease — EAS consensus (Ference 2017) — European Heart Journal / PubMed
  14. [14] CEA test — smoking raises CEA levels — MedlinePlus (NIH)
  15. [15] CA-125 blood test — benign causes of a raised level — MedlinePlus (NIH)
  16. [16] AASLD practice guidance on hepatocellular carcinoma (Singal 2023) — surveillance in cirrhosis and chronic hepatitis B — Hepatology / PubMed
  17. [17] Biotin can significantly interfere with certain lab tests (links the 2019 safety communication) — US Food and Drug Administration

Conditions this exam is used for

Comprehensive Blood Panel — Frequently Asked Questions

Do I need to fast before a blood panel?

It depends on the tests. A fasting glucose needs at least 8 hours without food. HbA1c does not need fasting, and US cholesterol guidance (ACC/AHA 2026) accepts a non-fasting lipid panel for most people. If you take insulin or other diabetes medicines, ask how to adjust them before any fast. Your coordinator confirms the rules for your tests when you book.

Can a blood test detect cancer?

Not as a screening test. Tumor markers such as CEA, CA-125 and CA 19-9 can be normal when cancer is present and raised for harmless reasons. The US National Cancer Institute says they have generally not worked well for screening. Their established use is monitoring a known cancer. PSA is a separate case: the USPSTF treats screening at 55–69 as an individual decision and recommends against it from 70.

What is included in a comprehensive blood panel?

A panel usually draws from a complete blood count, glucose and HbA1c, a lipid panel, and liver and kidney function. Thyroid hormones are added when there is a reason, since the USPSTF finds the evidence insufficient for routine thyroid screening without symptoms. Some packages add tumor markers. The exact tests depend on the package. Each value is reported next to the laboratory's reference range; report language and turnaround are confirmed when you book.

How is a blood panel different from imaging?

They answer different questions. Blood work measures your body's chemistry — sugar, fats, organ function, hormones — while imaging shows the physical structure of an organ. A clinician adds imaging when a result or symptom raises a specific question, not because a panel is incomplete without it.

Comprehensive Blood Panel at New Dawn Health

Current bookable prices from our catalogue.

Book it on its own

  • Possible add-on — availability depends on the selected package and partner clinic and is confirmed during booking $249 USD

Screen smart. Travel once. Know where you stand.

Compare screening packages, see exactly what each one includes, or talk to a coordinator about fitting Comprehensive Blood Panel into your visit to Taiwan.